Artificial Dermis Global Market Report 2026

Artificial dermis refers to a bioengineered skin substitute developed to replace or support damaged dermal tissue during wound healing and skin regeneration. It is commonly manufactured from collagen, silicone, or other biocompatible materials and is widely used in burn care, reconstructive surgery, and the treatment of chronic wounds.

The primary product types of artificial dermis include acellular dermal matrix, cellular dermal substitute, biosynthetic dermal scaffold, and composite dermal substitute. Acellular dermal matrix refers to a biologically derived scaffold with cellular components removed, providing structural support for tissue regeneration and wound healing. These products are manufactured using materials such as collagen-based, silicone-based, hyaluronic acid-based, and synthetic polymer-based materials and are distributed through direct sales, distributors, and online sales. The various applications include burn treatment, chronic wound management, surgical reconstruction, and trauma and skin defect repair, and they are used by several end users such as hospitals, specialty clinics, ambulatory surgical centers, and burn centers.

Tariffs are influencing the artificial dermis market by increasing the cost of imported collagen, silicone, specialty biomaterials, and medical-grade manufacturing components required for dermal substitute production. This is increasing production costs and affecting the availability of advanced skin regeneration products, particularly in regions dependent on imported raw materials such as Asia-Pacific and Europe. Material-intensive segments, including acellular dermal matrix, biosynthetic dermal scaffold, and composite dermal substitute, are experiencing the greatest impact due to global supply chain dependencies. However, tariffs are also encouraging local biomaterial manufacturing, regional supplier diversification, and increased investment in domestic tissue engineering and wound care production ecosystems, creating long-term resilience in the market.

The artificial dermis market research report is one of a series of new reports from The Business Research Company that provides artificial dermis market statistics, including artificial dermis industry global market size, regional shares, competitors with a artificial dermis market share, detailed artificial dermis market segments, market trends and opportunities, and any further data you may need to thrive in the artificial dermis industry. This artificial dermis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial dermis market size has grown strongly in recent years. It will grow from $1.66 billion in 2025 to $1.81 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period was driven by increasing incidence of severe burn injuries, growing number of reconstructive surgical procedures, rising prevalence of chronic wounds, expanding healthcare infrastructure, and improving availability of advanced wound care products.

The artificial dermis market size is expected to see strong growth in the next few years. It will grow to $2.56 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth during the forecast period is driven by growing demand for regenerative medicine solutions, increasing adoption of bioengineered skin substitutes, rising investment in tissue engineering research, expanding access to specialized wound care centers, and increasing focus on improving post-surgical healing outcomes. Major trends during the forecast period include increasing adoption of advanced bioengineered skin substitutes, growing demand for collagen-based dermal regeneration solutions, rising use of composite dermal substitutes in reconstructive surgery, expansion of artificial dermis applications in chronic wound management, and increasing development of next-generation biocompatible dermal scaffolds.

The increasing incidence of burn injuries is expected to drive the growth of the artificial dermis market in the coming years. Burn injuries refer to tissue damage caused by exposure to heat, chemicals, electricity, radiation, or friction, affecting the skin and underlying tissues. The rising occurrence of burn injuries is primarily attributed to the growing frequency of household and industrial accidents, which are often associated with unsafe cooking practices, electrical risks, chemical exposure, and insufficient workplace safety measures. Artificial dermis supports burn injury treatment by acting as a temporary or permanent skin substitute that facilitates wound closure, encourages tissue regeneration, and minimizes scarring and infection risks in patients suffering from extensive skin damage. For example, in October 2023, according to the International Burn Injury Database (iBID), a US-based organization, burns and scalds among children increased by 45% during the first six months of 2023 compared with the same period in 2022, while incidents involving adults and elderly individuals caused by hot water bottles increased by 19%. Therefore, the increasing incidence of burn injuries is driving the growth of the artificial dermis market.

The growing number of trauma and accident cases is expected to drive the growth of the artificial dermis market in the coming years. Trauma and accident cases refer to medical conditions involving injuries caused by sudden external forces, including road traffic collisions, falls, burns, or physical violence, that require immediate medical assessment and treatment. The increasing number of trauma and accident cases is driven by rising road traffic density, which contributes to increased congestion, greater exposure among road users, and a higher probability of accidents. Artificial dermis assists trauma and accident patients by providing a temporary or permanent skin substitute that supports wound closure, lowers infection risks, and accelerates tissue regeneration in severe injuries. For example, in October 2024, according to the Department of Health Alaska, a US-based government department, approximately 3,373 individuals in Alaska experienced traumatic brain injuries (TBI) in 2023. This number includes both fatal cases and non-fatal injuries that received treatment and were discharged from hospitals or emergency departments (ED). Therefore, the growing number of trauma and accident cases is driving the growth of the artificial dermis market.

In April 2023, Essex Bio-Technology Ltd., a China-based biopharmaceutical company that provides collagen-based artificial dermis products, and Gunze Limited entered into a collaboration agreement in mainland China to commercialize PELNAC, a bioresorbable dermal substitute used in advanced wound care applications. Through this partnership, Essex Bio-Technology Ltd. and Gunze Limited aim to enhance the availability and distribution of artificial dermis solutions in China by combining clinical wound care expertise with established regional commercialization capabilities, thereby improving access to regenerative wound healing technologies for surgical and chronic wound management. Gunze Limited is a Japan-based diversified manufacturer involved in textiles, plastics, and medical materials, including advanced wound care products.

Major companies operating in the artificial dermis market are Aroa Biosurgery Limited, AVITA Medical Inc., Elutia Inc., ConvaTec Group plc, Gunze Limited, Integra LifeSciences Holdings Corporation, LifeNet Health Inc., Medline Industries LP, MiMedx Group Inc., Molnlycke Health Care AB, MTF Biologics, Organogenesis Holdings Inc., Parametrics Medical LLC, PolyNovo Limited, Smith & Nephew plc, Surgenex LLC, Tides Medical LLC, Tissue Regenix Group plc, Vericel Corporation, Vivex Biologics Inc., Zimmer Biomet Holdings Inc.

North America was the dominating region in the artificial dermis market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the artificial dermis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial dermis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial dermis market consists of sales of products such as collagen-based artificial dermis, silicone-based dermal substitutes, biodegradable skin matrices, acellular dermal matrices, and tissue-engineered skin substitutes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Dermis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial dermis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial dermis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial dermis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Acellular Dermal Matrix; Cellular Dermal Substitute; Biosynthetic Dermal Scaffold; Composite Dermal Substitute
• 2) By Material: Collagen Based; Silicone Based; Hyaluronic Acid Based; Synthetic Polymer Based
• 3) By Distribution Channel: Direct Sales; Distributors; Online Sales
• 4) By Application: Burn Treatment; Chronic Wound Management; Surgical Reconstruction; Trauma And Skin Defect Repair
• 5) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Burn Centers
• Subsegments:
• 1) By Acellular Dermal Matrix: Human Acellular Dermal Matrix; Porcine Acellular Dermal Matrix; Bovine Acellular Dermal Matrix; Fish Derived Acellular Dermal Matrix
• 2) By Cellular Dermal Substitute: Fibroblast Based Dermal Substitute; Keratinocyte Based Dermal Substitute; Stem Cell Based Dermal Substitute; Bilayer Cellular Dermal Substitute
• 3) By Biosynthetic Dermal Scaffold: Collagen Based Scaffold; Silicone Based Scaffold; Hydrogel Based Scaffold; Polymeric Scaffold
• 4) By Composite Dermal Substitute: Collagen Silicone Composite; Hydrogel Composite; Biopolymer Composite; Hybrid Dermal Matrix
• Companies Mentioned: Aroa Biosurgery Limited; AVITA Medical Inc.; Elutia Inc.; ConvaTec Group plc; Gunze Limited; Integra LifeSciences Holdings Corporation; LifeNet Health Inc.; Medline Industries LP; MiMedx Group Inc.; Molnlycke Health Care AB; MTF Biologics; Organogenesis Holdings Inc.; Parametrics Medical LLC; PolyNovo Limited; Smith & Nephew plc; Surgenex LLC; Tides Medical LLC; Tissue Regenix Group plc; Vericel Corporation; Vivex Biologics Inc.; Zimmer Biomet Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.